The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Loss from discontinued operations | 0 |
| Net cash (used in) discontinued operations | 0 |
| Fair value of shares issued from convertible note extinguishment | 0 |
| Bad debt expense | 0 |
| Gain on sale of srm stock | 0 |
| Accrued loss on settlements | 0 |
| Unrealized gain/loss on marketable securities | 0 |
| Loss from operations | -68,185,762 |
| Depreciation and amortization expense | 654,378 |
| Fair value of stock-based compensation | 9,754,578 |
| Fair value of options issued for services rendered | 1,145,543 |
| Fair value of common stock issued for services | 2,099,503 |
| Fair value of common stock issued for settlement | 918,602 |
| Fair value of common stock issued for bonus | 792,500 |
| Fair value of srm shares granted in connection with settlement | 391,000 |
| Unrealized gain/loss on equity investment | -40,542 |
| Unrealized loss on digital asset | 35,372,217 |
| Exchange of common stock for series a preferred stock | -120,446 |
| Realized gain/loss on sale of marketable securities | 13,275,054 |
| Revenue on digital assets | 1,812,352 |
| Prepaid expenses and deposits | 320,604 |
| Right of use asset | -356,056 |
| Accounts receivable | -362,706 |
| Note receivable | -126,512 |
| Inventory | 185,459 |
| Accounts payable | 1,520,608 |
| Accrued liabilities | 292,517 |
| Lease liability | -395,162 |
| Impairment expense | 4,950,950 |
| Net cash (used in) continuing operating activities | -25,275,735 |
| Cash received from sale of marketable securities | 0 |
| Cash paid for investment | 0 |
| Cash paid for purchase of assets | 0 |
| Purchase of equipment | 0 |
| Cash received from sale of investments | 12,785,556 |
| Purchase of intangible assets | 834,116 |
| Purchase of digital assets | 5,000,037 |
| Investment in yerba | 925,000 |
| Acquisition of yerba | 201,958 |
| Net cash provided by (used in) investing activities | 5,824,445 |
| Proceeds from issuance of shares for warrant conversions | 0 |
| Cash received upon exercise of options | 0 |
| Deconsolidation of subsidiary | 0 |
| Proceeds from shares issued for private placements | 4,971,971 |
| Repayments of convertible notes | 4,508,315 |
| Proceeds from issuance of common stock | 20,367,158 |
| Proceeds from warrant purchase agreement | 550,000 |
| Net cash provided by financing activities | 21,380,814 |
| Change in cash | 1,929,524 |
| Cash at beginning of period | 348,816 |
| Cash at end of period | 2,278,340 |
BONK, INC. (BNKK)
BONK, INC. (BNKK)